Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more

PrincipalinvestigatorStart date: 2012-12-24

Research Network

Collaboration Network

3 collaborators·2 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Acute Myeloid Leukemia With FLT3/ITD Mutation1 Acute Myeloid Leukemia With Gene Mutations1 Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM1 Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP2141 Anemia, Aplastic1 Leukemia, Lymphocytic, Chronic, B-Cell1 Chronic Myelogenous Leukemia, BCR-ABL1 Positive1 Leukemia, Myelomonocytic, Chronic1

Affiliations

Thomas Jefferson University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Neal Flomenberg, MD

Thomas Jefferson University

Very Similar

7 trials

Shared therapeutic areas:

Hodgkin DiseaseLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin+18 more

Worked with same sponsors:

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborated on 1 trial

Similarity Score214%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

24 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma, FollicularAnemia, Aplastic+4 more

Similarity Score10%

David Avigan, MD

Beth Israel Deaconess Medical Center

17 trials

Shared therapeutic areas:

Multiple MyelomaAnemia, AplasticHodgkin Disease+3 more

Similarity Score9%

Arnon Nagler, MD

Chaim Sheba Medical Center

12 trials

Shared therapeutic areas:

Hodgkin DiseaseMultiple MyelomaLymphoma, Non-Hodgkin+2 more

Similarity Score7%

Yves Beguin, MD, PhD

CHU-ULg

7 trials

Shared therapeutic areas:

Hodgkin DiseaseLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin+2 more

Similarity Score7%

Jorge Cortes, MD

M.D. Anderson Cancer Center

24 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicPrimary Myelofibrosis+1 more

Similarity Score6%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple MyelomaLeukemia, Lymphocytic, Chronic, B-Cell

Similarity Score4%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

16 trials

Shared therapeutic areas:

Refractory Acute Myeloid LeukemiaMyelodysplastic SyndromesAcute Myeloid Leukemia With Gene Mutations

Similarity Score4%

Helen Heslop, MD

Baylor College of Medicine

17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-CellHodgkin Disease

Similarity Score4%

Michael B Gill

Power Life Sciences Inc.

105 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, FollicularMultiple Myeloma

Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01760655Phase 2PrincipalInvestigator

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more

Completed

All 1 trials loaded